stockrow
Friday 6 November 2026
Export BLTE’s income statement to Excel — free account
Belite Bio, Inc. Sponsored ADR
BLTE Healthcare Biotechnology
- EPS
- −40.0%
- Free cash flow
- +64.7%
Quarter to June 2026, against a year earlier
154.46
11.27
+7.87%
Follow BLTE
Alert me
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | |
|---|---|---|---|---|---|---|
Cash and Short Term Investments |
492.42 | 145.15 | 88.16 | 42.09 | 17.34 | 25.62 |
Receivables |
0.70 | 0.58 | 0.84 | 0.00 | 0.02 | 0.04 |
Total current assets |
494.27 | 147.07 | 89.94 | 42.81 | 17.43 | 25.67 |
Property, Plant, Equpment (Net) |
0.34 | 0.44 | 0.49 | 0.54 | 0.09 | 0.05 |
Long-Term Investments |
280.17 | — | — | — | — | — |
Goodwill and Intangible Assets (Total) |
0.02 | 0.03 | — | — | — | — |
Long-term assets (Other) |
5.32 | 4.06 | 3.40 | 0.12 | 0.01 | 0.03 |
Total non-current assets |
286.28 | 5.06 | 4.70 | 1.47 | 0.92 | 0.07 |
Total Assets |
780.56 | 152.13 | 94.64 | 44.27 | 18.35 | 25.74 |
Accrued Expenses |
9.64 | 5.76 | 3.33 | 1.91 | 1.56 | 0.95 |
Total current liabilities |
9.88 | 6.05 | 3.63 | 2.10 | 1.64 | 0.97 |
Liabilities (Preferred Stock) |
— | — | — | — | 31.81 | 31.81 |
Total non-current liabilities |
0.19 | 0.26 | 0.58 | 0.67 | 31.81 | 31.81 |
Total liabilities |
10.07 | 6.31 | 4.21 | 2.77 | 33.44 | 32.78 |
Additional Paid In Capital |
956.28 | 254.13 | 162.31 | 81.76 | 12.33 | 10.56 |
Common Stock (Net) |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Retained Earnings |
(185.26) | (107.65) | (71.50) | (39.87) | (27.22) | (17.56) |
Common Equity (Total) |
770.49 | 145.82 | 90.43 | 41.50 | (15.09) | (7.04) |
Shareholders Equity (Total) |
770.49 | 145.82 | 90.43 | 41.50 | (15.09) | (7.04) |
Shareholders Equity and Liabilities (Total) |
780.56 | 152.13 | 94.64 | 44.27 | 18.35 | 25.74 |
Shares (Common) |
39.34 | 31.83 | 29.15 | 24.90 | 10.27 | 9.57 |
Shareholders Equity (Tangible) |
770.47 | 145.79 | 90.43 | 41.50 | (15.09) | (7.04) |
Net Debt |
(492.42) | (145.15) | (88.16) | (42.09) | (17.34) | (25.62) |
Total Debt |
— | — | — | 0.87 | 31.81 | 31.81 |
In millions of $ except per-share values · columns are period end dates